Specifically, we observed more CD4+ and CD8+ T cells, including increased numbers of activated central memory (CD44+CD62L+) and naive (CD44− CD62L+) T cells, after tumour cell engraftment at ZT9 (Extended Data Fig. 3e,f). The gene discussed is CD8A; the disease is neoplasm.